| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at Baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | | Title | Denominators | Categories |
|---|
| | |
| |
| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 4 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Runny Nose as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at Baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 4 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Symptoms of Congestion as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS at Baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 4 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Itching as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at Baseline | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 4 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Nasal Sneezing as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | The Visual analog scale is scored from 0-10, with 0 being not a problem and 10 being unbearable. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | |
| Primary | Change in Maximum Optical Density Determined Via Optical Rhinometry | Optical rhinometry provides continuous measurement of blood flow in nasal vessels (via optical density measurements), which serves as an indirect assessment of nasal congestion. A greater decrease in optical density (OD) from baseline indicates less nasal blood flow and decreased congestion relative to baseline. | Data were not collected for 6 participants in the treatment arm. | Posted | | Mean | Standard Deviation | log ratio of light in to light out (OD) | | baseline, immediately post first treatment on Day 1 | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at Baseline | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. | | Posted | | Mean | Standard Deviation | score on a scale | | baseline | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at 4 Weeks Post Treatment | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. | | Posted | | Mean | Standard Deviation | score on a scale | | 4 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| |
| Primary | Total Nasal Symptom Score as Measured by the Visual Analog Scale (VAS) at 12 Weeks Post Treatment | Total Nasal Symptom score is measured as the sum of four symptom scores for runny nose, nasal symptoms of congestion, nasal itching and sneezing. Each symptom is scored from 0-10, with 0 being not a problem and 10 being unbearable. The Total nasal symptom score ranges from 0 - 40, the lower the score the better the outcome. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| |
| Secondary | Change in Local Immunoglobulin E (IgE) Level | The IgE levels will be obtained from the brush biopsy of the inferior turbinates. Change from baseline in local Immunoglobulin E (IgE) level after 12 weeks post treatment. Data reported is the 12 weeks post treatment value minus the baseline value. | Data were not collected for 5 participants in the Treatment arm. | Posted | | Mean | Standard Deviation | kU/L | | baseline, 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| |
| Primary | Maximum Optical Density Determined Via Optical Rhinometry | | Data were not collected for this outcome measure. | Posted | | | | | | 12 weeks post treatment | | | | ID | Title | Description |
|---|
| OG000 | Treatment | Intranasal capsaicin: Intranasal capsaicin, 5 applications each delivering 2 micrograms in each nostril, separated by 1 hour. topical lidocaine: The nose will be pre-treated with topical lidocaine 15 minutes before each application |
| | | |